Publications by authors named "FIRMAT J"
Article Synopsis
- HIV vaccine development has faced major challenges for over 40 years, with all trials producing disappointing results, leading to uncertainty in the field.
- Currently, startup biotech firms are the main players in this arena but encounter several obstacles like changing prevention methods, decreased interest in vaccine research, and funding issues.
- The viewpoint suggests a multi-faceted approach to support these biotech companies, emphasizing improved communication, innovation, and strategic funding models.
A retrospective study of 500 consecutive cases of acute renal failure (ARF) in a period covering 1978 through 1991 is presented. A total of 316 females and 182 males with an average age of 46.4 years (14 to 84) had a global survival rate of 68%.
View Article and Find Full Text PDF[Nobel Prize of Medicine 1990. Clinical application of transplantations].
Medicina (B Aires)
August 1992
Ten patients with acute renal failure post-septic abortion were studied. Two groups of patients are described in terms of duration of oliguria, number of dialysis per patient and maximal concentration of BUN during the acute episode of tubular necrosis. Despite different oliguric periods, when the patients reached 500 ml of urine volume in 24 hours, the recovery of diuresis was similar in both groups as well as the decrease of BUN concentration at the end of the hemodialysis period.
View Article and Find Full Text PDF[Present status of the dialysis treatment in chronic renal failure].
Medicina (B Aires)
September 1975
[Septic abortion with acute renal insufficiency. Study of 150 cases].
Obstet Ginecol Lat Am
February 1976
[Septic abortion with acute renal insufficiency. Study of 150 cases].
Medicina (B Aires)
January 1974